|
|
Volumn 20, Issue 5, 2002, Pages 467-473
|
|
The role of the pharmaceutical industry in drug development in dermatology
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADAPALENE;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIHISTAMINIC AGENT;
ANTIHYPERTENSIVE AGENT;
ANTIINFECTIVE AGENT;
ASCOMYCIN;
BENZOYL PEROXIDE;
CHOLESTEROL;
COLECALCIFEROL;
COLLAGEN;
COSMETIC;
EFLORNITHINE;
FINASTERIDE;
IMIQUIMOD;
INFLIXIMAB;
MINOXIDIL;
RETINOIC ACID;
TACROLIMUS;
THALIDOMIDE;
WOUND HEALING PROMOTING AGENT;
AGING;
BLOOD PRESSURE;
BORDERLINE HYPERTENSION;
CORONARY STENT;
CROHN DISEASE;
CUTANEOUS PARAMETERS;
DEMOGRAPHY;
DERMATOLOGY;
DERMIS;
DIABETES MELLITUS;
DISEASE COURSE;
DOCTOR PATIENT RELATION;
DRUG ACTIVITY;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG INDUSTRY;
DRUG SAFETY;
ECONOMIC DEVELOPMENT;
ENDOCRINE DISEASE;
GENE MAPPING;
GENOME;
GOVERNMENT;
HAIR GROWTH;
HEALTH CARE PERSONNEL;
HEALTH CARE SYSTEM;
HIP PROSTHESIS;
HUMAN;
ISCHEMIA;
KNEE PROSTHESIS;
MOLECULAR BIOLOGY;
MUSCULOSKELETAL DISEASE;
NEUROLOGIC DISEASE;
PHOTODYNAMICS;
PHYSICIAN;
PRIORITY JOURNAL;
PSORIASIS;
REVIEW;
RHEUMATIC DISEASE;
SIDE EFFECT;
SKIN DISEASE;
SOCIAL ENVIRONMENT;
SOCIAL SECURITY;
SOCIOECONOMICS;
WOUND HEALING;
|
|
EID: 0036756970
PISSN: 0738081X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0738-081X(02)00276-6 Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
